Immunome (IMNM) Insider Trading & Ownership $13.71 -0.58 (-4.06%) As of 11:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immunome (NASDAQ:IMNM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.69%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$3.35MNumber OfInsiders Selling(Last 12 Months)0 Get IMNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunome stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMNM Insider Buying and Selling by Quarter Immunome Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/3/2025Jean Jacques BienaimeDirectorBuy5,000$9.38$46,900.00 3/26/2025Clay B SiegallCEOBuy137,100$7.29$999,459.00 3/24/2025Jean Jacques BienaimeDirectorBuy7,000$8.21$57,470.00 3/24/2025Philip TsaiCTOBuy12,300$8.42$103,566.00 1/31/2025Clay B SiegallCEOBuy150,000$7.75$1,162,500.00 11/21/2024Clay B SiegallCEOBuy66,057$9.54$630,183.78 11/21/2024Philip TsaiCTOBuy21,000$9.43$198,030.00 11/21/2024Robert LechleiderInsiderBuy15,805$9.48$149,831.40 (Data available from 1/1/2013 forward) IMNM Insider Trading Activity - Frequently Asked Questions Who is on Immunome's Insider Roster? The list of insiders at Immunome includes Bruce Turner, Clay B Siegall, Jack Higgins, Jean Jacques Bienaime, Max Rosett, Philip Tsai, and Robert Lechleider. Learn more on insiders at IMNM. What percentage of Immunome stock is owned by insiders? 7.69% of Immunome stock is owned by insiders. Learn more on IMNM's insider holdings. Which Immunome insiders have been buying company stock? The following insiders have purchased IMNM shares in the last 24 months: Clay B Siegall ($2,792,142.78), Jean Jacques Bienaime ($229,090.00), Philip Tsai ($301,596.00), and Robert Lechleider ($149,831.40). How much insider buying is happening at Immunome? Insiders have purchased a total of 423,262 IMNM shares in the last 24 months for a total of $3,472,660.18 bought. Which Immunome insiders have been selling company stock? The following insiders have sold IMNM shares in the last 24 months: Jack Higgins ($49,089.32), and Max Rosett ($230,223.80). How much insider selling is happening at Immunome? Insiders have sold a total of 17,904 Immunome shares in the last 24 months for a total of $279,313.12 sold. Immunome Key ExecutivesDr. Clay B. Siegall Ph.D. (Age 63)President, CEO & Chairman Compensation: $1.43MDr. Jack Higgins Ph.D. (Age 44)Chief Scientific Officer Compensation: $956.34kDr. Robert J. Lechleider M.D. (Age 63)Chief Medical Officer Compensation: $512.49k More Insider Trading Tools from MarketBeat Related Companies KYMR Insider Trading MLTX Insider Trading AKRO Insider Trading ADMA Insider Trading SRRK Insider Trading MIRM Insider Trading ACAD Insider Trading ZLAB Insider Trading LNTH Insider Trading NAMS Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:IMNM) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersWhy This Titanium Explorer Caught Rio Tinto’s EyeAs U.S. defense spending crosses $1 trillion, drones, hypersonics, and next-gen aerospace are taking center st...Capital Trends | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
